DMD and neuromuscular disease caused by qualitative or quantitative defects of dystrophin: In order to shed light on the mechanisms responsible for the clinical manifestations of dystrophinopathy in females, we recruited a cohort of 47 DMD heterozygous females, 27 asymptomatic and 20 symptomatic.